CENTO, ALESSIA SOFIA
 Distribuzione geografica
Continente #
NA - Nord America 1.610
EU - Europa 1.036
AS - Asia 331
AF - Africa 10
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
Totale 3.001
Nazione #
US - Stati Uniti d'America 1.603
IT - Italia 307
CN - Cina 173
SE - Svezia 137
IE - Irlanda 123
DK - Danimarca 118
DE - Germania 86
UA - Ucraina 74
GB - Regno Unito 43
VN - Vietnam 43
FR - Francia 38
SG - Singapore 36
FI - Finlandia 28
JP - Giappone 27
BE - Belgio 19
AT - Austria 18
KR - Corea 15
ES - Italia 14
PL - Polonia 11
AU - Australia 8
HK - Hong Kong 8
IN - India 6
TW - Taiwan 6
CA - Canada 5
CH - Svizzera 5
EG - Egitto 5
NL - Olanda 5
EU - Europa 3
IR - Iran 3
TH - Thailandia 3
KZ - Kazakistan 2
MO - Macao, regione amministrativa speciale della Cina 2
MX - Messico 2
NO - Norvegia 2
PH - Filippine 2
RO - Romania 2
SN - Senegal 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AM - Armenia 1
BG - Bulgaria 1
BR - Brasile 1
CI - Costa d'Avorio 1
CL - Cile 1
GR - Grecia 1
HU - Ungheria 1
KH - Cambogia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SI - Slovenia 1
TR - Turchia 1
Totale 3.001
Città #
Ann Arbor 337
Chandler 261
Dublin 122
Torino 101
Ashburn 82
Beijing 69
Fairfield 63
Nyköping 62
Wilmington 61
Jacksonville 58
Houston 53
Frankfurt am Main 52
Turin 43
Dearborn 40
Dong Ket 35
Woodbridge 33
Seattle 32
Cambridge 31
Medford 29
Fremont 23
Pisa 21
Princeton 21
Villeurbanne 21
Singapore 20
Vienna 18
Redwood City 16
Brussels 15
Lappeenranta 14
Guangzhou 13
Boston 11
San Diego 10
Warsaw 10
London 9
San Mateo 9
Boardman 8
Chengdu 8
Helsinki 8
Chions 7
New York 7
Los Angeles 6
Tokyo 6
Umeda 6
Vigo 6
Zhengzhou 6
Aosta 5
Hangzhou 5
Hong Kong 5
Nanjing 5
San Mauro Torinese 5
Seoul 5
Taipei 5
Wuhan 5
Zurich 5
Hanover 4
Ilkley 4
Nakasuji 4
Shanghai 4
Upper Marlboro 4
Washington 4
Xian 4
Berkeley 3
Bra 3
Gava 3
Hebei 3
Milan 3
Munich 3
Nanchang 3
Nuremberg 3
Palermo 3
Riverton 3
Rochester 3
Samarate 3
San Francisco 3
Stockholm 3
Torre del Greco 3
Albizzate 2
Alessandria 2
Almaty 2
Amersfoort 2
Bonn 2
Borgaro Torinese 2
Castiglione 2
Catania 2
Central District 2
Clifton 2
Cobleskill 2
Durham 2
Fort Worth 2
Gangbuk-gu 2
Guiyang 2
Hefei 2
Kobe 2
Kunming 2
Lanzhou 2
Las Vegas 2
Leinì 2
Maastricht 2
Macao 2
Mapo-gu 2
Mountain View 2
Totale 2.031
Nome #
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study 312
SALIVAGE – EU JPI Project The “form” makes the difference: comprehensive two‐dimensional gas chromatography as highly informative fingerprinting tool to study the impact of fructose formulation on mice’s microbiota and its volatile metabolome signatures 218
Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver 193
Pyridoxamine prevents diet-induced insulin resistance through the regulation of ceramide/sphingosine/sphingosine-1-phosphate equilibrium in mice liver 179
Advanced Glycation End Products Inhibition Restores Sphingolipid Rheostat in Mice Liver and Prevents Diet-Induced Insulin Resistance 177
High-fructose intake as risk factor for neurodegeneration: Key role for carboxy methyllysine accumulation in mice hippocampal neurons 169
Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts 160
Identification of Annexina1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes 139
Effects of exogenous dietary advanced glycation end products on the cross-talk mechanisms linking microbiota to metabolic inflammation 137
Toxicological impact of high fructose intake on gut microbiota and liver/intestine integrity: Any differences between solid and liquid formulations? 126
The AGEs inhibitor pyridoxamine prevents kidney injury and dysfunction in mice fed high-fat high-fructose diet 120
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction 116
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice 112
KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction 108
Advanced glycation end products and chronic inflammation in adult survivors of childhood leukemia treated with hematopoietic stem cell transplantation 93
Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose 89
AGEs induce alterations of sphingolipids metabolism in the liver of genetically- and diet-induced diabetic mice 86
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades 82
Baricitinib counteracts metaflammation protecting against diet-induced metabolic abnormalities in mice 80
Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems 75
KRIT1/CCM1 Loss-of-function Mutations Impair Anti-glycative and Anti-oxidant Systems Worsening High Fructose Diet-induced Hepatic Dismetabolism 73
KRIT1/CCM1 loss-of-function affects sphingolipid metabolism inducing hepatosteatosis and predisposing to liver fibrosis and insulin-resistance 63
KRIT1/CCM1 loss-of-function impairs advanced glycation endproducts receptors and detoxification and worsens fructose diet-induced hepatic dysmetabolism 62
Inhibition of AGEs by pyridoxamine prevents diet-induced systemic inflammation and skeletal muscle insulin resistance by restoring SphK/S1P3/RhoA signalling 57
Genetic deletion of RAGE in db/db mice interferes in the liver with other AGE-receptors and AGE-detoxifying systems sustaining lipogenesis and inflammation 53
Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress 18
Exercise and Exercise Mimetics for the Treatment of Musculoskeletal Disorders 13
The BET inhibitor JQ1 targets fat metabolism and counteracts obesity 3
Totale 3.113
Categoria #
all - tutte 9.621
article - articoli 0
book - libri 0
conference - conferenze 3.261
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020411 2 0 4 73 38 47 46 38 49 30 44 40
2020/2021514 20 42 30 43 54 47 35 26 50 37 24 106
2021/2022739 57 46 59 58 65 46 55 58 33 50 117 95
2022/2023797 59 85 26 90 61 182 55 56 103 25 36 19
2023/2024349 40 54 21 20 23 31 13 32 11 35 36 33
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 3.113